CHRNA7 and lung cancer: The inhibition of growth and migration of A549 and NCI-H1299 lung cancer cells were also observed when exposed to a fusion protein consisting of α-conotoxin ImI (an α7 nAChR subtype antagonist) and human alpha fetoprotein domain 3 (AFP3), a prototype of anticancer agent [34].